STAT5A
MOLECULAR TARGETsignal transducer and activator of transcription 5A
STAT5A (signal transducer and activator of transcription 5A) is targeted by 5 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting STAT5A
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | lestaurtinib | 3.04 | 20 |
| 2 | momelotinib | 2.89 | 17 |
| 3 | suramin hexasodium | 2.83 | 16 |
| 4 | azd 1480 | 2.30 | 9 |
| 5 | Sorafenib | 0.69 | 1 |
About STAT5A as a Drug Target
STAT5A (signal transducer and activator of transcription 5A) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 5 compounds with documented STAT5A interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
STAT5A inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.